Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

How 1 sources are covering this

• CNBCLean R·1h ago

  Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

  Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.

  Read at CNBC →